During 2022, ICE Pharma developed a long-term sustainability strategy and a short-term roadmap that will guide our actions for the next three years. We describe the strategic choices that will define our way forward and the progress we’re making against our roadmap within this report.
We have set clear targets along four strategic pillars, supported by strong ESG governance and leadership. These pillars cover essential aspects of ESG within our value chain, influencing our ability to create value for our stakeholders.
These Pillars represent four priority areas with clear targets and commitment:
- Fighting illness through product innovation: serving our customers by providing innovative, safe, and high-quality pharmaceutical ingredients to help them build a healthier society.
- Accelerating sustainable operations: we work to monitor and reduce our emissions, energy and water consumption. We do this through robust ECG governance based on processes and accountability.
- Building strong relationships: We manage our supply chain in a transparent way with strong supplier relationships, corporate governance, and responsible business practices.
- Caring for people: our commitment to growing our people is focused on a transformational and inclusive culture while ensuring the wellbeing and development of our employees.
We describe the strategic choices that will define our way forward and the progress we are making against our roadmap within a report. You can download the full version here: